AARP Eye Center
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
WASHINGTON—The following is a statement from AARP Executive Vice President and Chief Advocacy & Engagement Officer Nancy LeaMond on the approval of two bills endorsed by AARP: Creating and...
WASHINGTON—Today, AARP announced the launch of ‘Stop Rx Greed,’ a nationwide campaign aimed at lowering prescription drug prices. The goal of AARP’s sustained campaign is to help drive...
WASHINGTON—Today, AARP released the following statement from Executive Vice President and Chief Advocacy & Engagement Officer Nancy LeaMond. The statement is in response to seven drug company...
WASHINGTON—AARP has opened applications for the 2019 AARP Community Challenge grant program to fund “quick-action” projects that spark change across the country. Now in its third year, the...
WASHINGTON—Primary care providers agree, almost unanimously, that family caregivers play a vital role in patient care and in better patient outcomes, according to a new survey by AARP Research.
WASHINGTON, DC—AARP CEO Jo Ann Jenkins released the following statement in response to the State of the Union address this evening: “In tonight’s State of the Union address, AARP was...
WASHINGTON, DC—Today AARP National Volunteer President Dr. Catherine Alicia Georges, EdD, RN, testified on Capitol Hill at the U.S. House Committee on Oversight and Reform about the impact of...
WASHINGTON, DC—The following is a statement from AARP Executive Vice President and Chief Advocacy & Engagement Officer Nancy LeaMond on yesterday’s court ruling in Texas v. United States:...
WASHINGTON, DC—Today AARP Executive Vice President and Chief Advocacy & Engagement Officer Nancy LeaMond released the following statement on Congress passing the Agriculture Improvement Act of 2018 (H.R. 2):
Today, AARP announced the launch of a major new advocacy campaign urging Congress to stand up to the pharmaceutical industry and protect seniors from any attempts to raise patient drug costs by...